NYSE · MOH

Molina Healthcare, Inc.

$197.55 -$2.74 (-1.37%) 1D After hours

Key Metrics

$10.46B
Market cap
55.61×
P/E · TTM
$45.08B
Revenue · TTM
$188.00M
Net income
EPS · TTM $3.43
Dividend yield
Free cash flow $251.00M
Beta · 1Y -0.05
EBITDA · TTM $414.00M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 23
    The stock moved +14.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 23
  • Feb 11
    From its Jan 29 high, the share price fell 34%.

    Peak close $184.93 on Jan 29; trough close $122.65 on Feb 11. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Feb 6
    The stock moved -25.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$10.46B
Enterprise value$4.97B
Shares outstanding52.2M
52-wk range$121.06 – $244.89
Avg volume · 20D680.3K
Net cash $5.48B
Book value / share$74.45
IndustryHospital & Medical Service Plans
ExchangeNYSE
About Molina Healthcare, Inc.
IPO dateJul 2, 2003
Employees19000

Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E55.61
P/S0.23
P/FCF41.65
EV/EBITDA12.01
EV/Sales0.11
Graham №$75.81

Profitability

Gross
Operating 0.5%
Net 0.4%
FCF 0.6%
ROE / ROIC 4.4% · -13.4%

Financial Health

Current ratio1.63
Quick ratio
Debt / equity0.92
Debt / EBITDA 9.10
Net cash $5.48B
Working capital$5.14B

Cash Flow · TTM

Operating CF $357.00M
Capex −$106.00M
Free cash flow $251.00M
Buybacks $500.00M
Dividends paid
Shareholder yield 4.8%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

4.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$75.81 vs $197.55
Trades 2.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings